Results 181 to 190 of about 15,047 (197)

Varenicline Improves Mood and Cognition During Smoking Abstinence

Biological Psychiatry, 2009
Freda Patterson, Ruben C Gur, Steven Siegel   +2 more
exaly  

Varenicline for opioid withdrawal in patients with chronic pain: A randomized, single-blinded, placebo controlled pilot trial

Addictive Behaviors, 2015
William Hooten
exaly  

Varenicline

Reactions Weekly, 2017
openaire   +1 more source

Population pharmacokinetic analysis of varenicline in adult smokers

British Journal of Clinical Pharmacology, 2009
Hélène M Faessel
exaly  

Single-Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers

Journal of Clinical Pharmacology, 2006
Hélène M Faessel
exaly  

Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition

Biochemical Pharmacology, 2009
Mihály Hajós, Mark J Majchrzak
exaly  

Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Neuropharmacology, 2007
exaly  

Discovery and development of varenicline for smoking cessation

Expert Opinion on Drug Discovery, 2018
Chloe J Jordan, Zheng-Xiong Xi
exaly  

Varenicline in the routine treatment of tobacco dependence: a pre–post comparison with nicotine replacement therapy and an evaluation in those with mental illness

Addiction, 2008
exaly  

Multiple‐Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers

Journal of Clinical Pharmacology, 2006
Hélène M Faessel
exaly